Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


27.05.2019

1 Acta Ophthalmol
1 Am J Kidney Dis
1 Am J Manag Care
1 Am J Med
2 Am J Ophthalmol
2 Ann Intern Med
1 Biochem Biophys Res Commun
1 Diabet Med
2 Diabetes
12 Diabetes Care
2 Diabetes Obes Metab
6 Diabetologia
1 Eur J Endocrinol
2 Invest Ophthalmol Vis Sci
1 J Biol Chem
4 J Clin Endocrinol Metab
2 J Diabetes Complications
1 J Immunol
1 Kidney Int
1 Lancet
3 Lancet Diabetes Endocrinol
1 Med Care
2 Metabolism
1 Nature
1 Pediatr Diabetes
3 PLoS One
2 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. NISHIDA K, Miura K, Sakaguchi H, Kamei M, et al
    The impact of spot size, spacing, pattern, duration and intensity of burns on the photocoagulation index in a geometric simulation of pan-retinal laser photocoagulation.
    Acta Ophthalmol. 2019;97:e551-e558.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  2. ALLEGRETTI AS, Zhang W, Zhou W, Thurber TK, et al
    Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD.
    Am J Kidney Dis. 2019 May 13. pii: S0272-6386(19)30665.
    PubMed     Text format     Abstract available


    Am J Manag Care

  3. PAWASKAR M, Bilir SP, Kowal S, Gonzalez C, et al
    Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetes.
    Am J Manag Care. 2019;25:231-238.
    PubMed     Text format     Abstract available


    Am J Med

  4. WANG Y, Lee DC, Brellenthin AG, Eijsvogels TMH, et al
    Leisure-Time Running Reduces the Risk of Incident Type 2 Diabetes.
    Am J Med. 2019 May 16. pii: S0002-9343(19)30421.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  5. LAVILLE V, Kang JH, Cousins CC, Iglesias AI, et al
    Genetic correlations between diabetes and glaucoma: an analysis of continuous and dichotomous phenotypes.
    Am J Ophthalmol. 2019 May 20. pii: S0002-9394(19)30245.
    PubMed     Text format     Abstract available

  6. MAN RE, Gan AT, Gupta P, Fenwick EK, et al
    Is Myopia associated with the Incidence and Progression of Diabetic Retinopathy?
    Am J Ophthalmol. 2019 May 16. pii: S0002-9394(19)30232.
    PubMed     Text format     Abstract available


    Ann Intern Med

  7. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Cardiovascular Risk, Blood Pressure, and Cognition in a Patient With Diabetes.
    Ann Intern Med. 2019;170:CG1.
    PubMed     Text format    

  8. GOEL A
    Review: Viscous fiber reduces HbA1c, fasting glucose, and insulin resistance in type 2 diabetes.
    Ann Intern Med. 2019;170:JC51.
    PubMed     Text format    


    Biochem Biophys Res Commun

  9. VINES K, Li R, Geetha T, Broderick TL, et al
    Nerve growth factor receptor TrkA signaling in streptozotocin-induced type 1 diabetes rat brain.
    Biochem Biophys Res Commun. 2019 May 18. pii: S0006-291X(19)30813.
    PubMed     Text format     Abstract available


    Diabet Med

  10. YAMAMOTO JM, Corcoy R, Donovan LE, Stewart ZA, et al
    Maternal glycaemic control and risk of neonatal hypoglycaemia in Type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial.
    Diabet Med. 2019 May 20. doi: 10.1111/dme.13988.
    PubMed     Text format     Abstract available


    Diabetes

  11. MEZZA T, Cinti F, Cefalo CMA, Pontecorvi A, et al
    beta-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.
    Diabetes. 2019;68:1121-1129.
    PubMed     Text format     Abstract available


  12. In This Issue of Diabetes.
    Diabetes. 2019;68:1097-1098.
    PubMed     Text format    


    Diabetes Care

  13. DAVIS WA, Hamilton EJ, Bruce DG, Davis TME, et al
    Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109.
    Diabetes Care. 2019;42:e101.
    PubMed     Text format    


  14. In This Issue of Diabetes Care.
    Diabetes Care. 2019;42:989-990.
    PubMed     Text format    

  15. WOLFSDORF JI, Ratner RE
    SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution.
    Diabetes Care. 2019;42:991-993.
    PubMed     Text format    

  16. COWIE CC
    Diabetes Diagnosis and Control: Missed Opportunities to Improve Health : The 2018 Kelly West Award Lecture.
    Diabetes Care. 2019;42:994-1004.
    PubMed     Text format     Abstract available

  17. HELLER SR
    Robert Tattersall, a Diabetes Physician Ahead of His Time.
    Diabetes Care. 2019;42:1005-1008.
    PubMed     Text format    

  18. STANDL E, Green JB, Holman RR
    Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163.
    Diabetes Care. 2019;42:e95.
    PubMed     Text format    

  19. FEIG DS, Corcoy R, Donovan LE, Murphy KE, et al
    Response to Comment on Feig et al. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 2018;41:2471-2479.
    Diabetes Care. 2019;42:e98-e99.
    PubMed     Text format    

  20. MONNIER L, Colette C, Owens D
    Comment on Echouffo-Tcheugui et al. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. Diabetes Care 2019;42:486-493.
    Diabetes Care. 2019;42:e104.
    PubMed     Text format    

  21. SACHA JM, Lane WS
    Comment on Feig et al. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 2018;41:2471-2479.
    Diabetes Care. 2019;42:e96-e97.
    PubMed     Text format    

  22. EVRON JM, Herman WH, McEwen LN
    Response to Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576-584.
    Diabetes Care. 2019;42:e103.
    PubMed     Text format    

  23. STANKEVICH L, Galhaud JP, Kuvshinov R, Helmer C, et al
    Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576-584.
    Diabetes Care. 2019;42:e102.
    PubMed     Text format    

  24. BUZKOVA P, Barzilay JI
    Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109.
    Diabetes Care. 2019;42:e100.
    PubMed     Text format    


    Diabetes Obes Metab

  25. WEISMAN A, Tomlinson GA, Lipscombe LL, Perkins BA, et al
    Author's reply to 'The role of long-term effects of allopurinol on cardiovascular outcomes and all-cause mortality in diabetes'.
    Diabetes Obes Metab. 2019 May 21. doi: 10.1111/dom.13789.
    PubMed     Text format     Abstract available

  26. ABTAHI S
    The role of long-term effects of allopurinol on cardiovascular outcomes and all-cause mortality in diabetes.
    Diabetes Obes Metab. 2019 May 21. doi: 10.1111/dom.13790.
    PubMed     Text format    


    Diabetologia

  27. PAGNI PP, Wolf A, Lo Conte M, Yeh R, et al
    CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor.
    Diabetologia. 2019 May 17. pii: 10.1007/s00125-019-4893.
    PubMed     Text format    

  28. MAIR C, Wulaningsih W, Jeyam A, McGurnaghan S, et al
    Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.
    Diabetologia. 2019 May 18. pii: 10.1007/s00125-019-4900.
    PubMed     Text format     Abstract available

  29. OLAIYA MT, Wedekind LE, Hanson RL, Sinha M, et al
    Birthweight and early-onset type 2 diabetes in American Indians: differential effects in adolescents and young adults and additive effects of genotype, BMI and maternal diabetes.
    Diabetologia. 2019 May 20. pii: 10.1007/s00125-019-4899.
    PubMed     Text format     Abstract available

  30. MANGIALARDI G, Ferland-McCollough D, Maselli D, Santopaolo M, et al
    Correction to: Bone marrow pericyte dysfunction in individuals with type 2 diabetes.
    Diabetologia. 2019 May 21. pii: 10.1007/s00125-019-4902.
    PubMed     Text format     Abstract available

  31. BANCKS MP, Carson AP, Lewis CE, Gunderson EP, et al
    Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.
    Diabetologia. 2019 May 22. pii: 10.1007/s00125-019-4901.
    PubMed     Text format     Abstract available

  32. GOYAL A, Gupta Y, Kalaivani M, Sankar MJ, et al
    Concordance of glycaemic and cardiometabolic traits between Indian women with history of gestational diabetes mellitus and their spouses: an opportunity to target the household.
    Diabetologia. 2019 May 18. pii: 10.1007/s00125-019-4903.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  33. BENHALIMA K, Van Crombrugge P, Moyson C, Verhaeghe J, et al
    Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria
    Eur J Endocrinol. 2019;180:353-363.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  34. MORJARIA R, Alexander I, Purbrick RMJ, Safa R, et al
    Impact of Diabetic Retinopathy on Sleep, Mood, and Quality of Life.
    Invest Ophthalmol Vis Sci. 2019;60:2304-2310.
    PubMed     Text format     Abstract available

  35. GRAUSLUND J, Frydkjaer-Olsen U, Peto T, Fernandez-Carneado J, et al
    Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.
    Invest Ophthalmol Vis Sci. 2019;60:2257-2262.
    PubMed     Text format     Abstract available


    J Biol Chem

  36. LI Y, Deng S, Peng J, Wang X, et al
    MicroRNA-223 is essential for maintaining functional beta-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways.
    J Biol Chem. 2019 May 22. pii: RA119.007755. doi: 10.1074/jbc.RA119.007755.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  37. RAHMAN ML, Shrestha D, Workalemahu T, Wu J, et al
    Maternal and Offspring Genetic Risk of Type 2 Diabetes and Offspring Birthweight Among African Ancestry Populations.
    J Clin Endocrinol Metab. 2019 May 23. pii: 5497095. doi: 10.1210/jc.2018-02756.
    PubMed     Text format     Abstract available

  38. WANG Y, Bucher M, Myatt L
    Use of Glucose, Glutamine and Fatty Acids for Trophoblast Respiration in Lean, Obese and Gestational Diabetic Women.
    J Clin Endocrinol Metab. 2019 May 22. pii: 5492493. doi: 10.1210/jc.2019-00166.
    PubMed     Text format     Abstract available

  39. TAKITA M, Jimbo E, Fukui T, Aida K, et al
    Unique Inflammatory Changes in Exocrine and Endocrine Pancreas in Enterovirus-induced Fulminant Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 May 21. pii: 5491619. doi: 10.1210/jc.2018-02672.
    PubMed     Text format     Abstract available

  40. VENNERI MA, Barbagallo F, Fiore D, De Gaetano R, et al
    PDE5 Inhibition Stimulates Tie2-Expressing Monocytes and Angiopoietin-1 Restoring Angiogenic Homeostasis in Diabetes.
    J Clin Endocrinol Metab. 2019;104:2623-2636.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  41. UJUETA F, Arenas IA, Escolar E, Diaz D, et al
    The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
    J Diabetes Complications. 2019 Apr 14. pii: S1056-8727(18)31417.
    PubMed     Text format     Abstract available

  42. KANNENKERIL D, Karg MV, Bosch A, Ott C, et al
    Tissue sodium content in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2019 Apr 16. pii: S1056-8727(18)31353.
    PubMed     Text format     Abstract available


    J Immunol

  43. JAMISON BL, Neef T, Goodspeed A, Bradley B, et al
    Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.
    J Immunol. 2019 May 20. pii: jimmunol.1900127. doi: 10.4049/jimmunol.1900127.
    PubMed     Text format     Abstract available


    Kidney Int

  44. CHEN G, Chen H, Ren S, Xia M, et al
    Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30273.
    PubMed     Text format     Abstract available


    Lancet

  45. WATTS G
    Shitaye Alemu Balcha: committed to rural health care in Ethiopia.
    Lancet. 2019;393:1797.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  46. LIMA LMTR
    Insulin resistance underlying type 2 diabetes.
    Lancet Diabetes Endocrinol. 2019;7:424.
    PubMed     Text format    

  47. SCHMIDT MI, Bracco PA, Duncan BB
    Insulin resistance underlying type 2 diabetes - Authors' reply.
    Lancet Diabetes Endocrinol. 2019;7:424-425.
    PubMed     Text format    

  48. THE LANCET DIABETES ENDOCRINOL
    Nutrition, weight loss, and type 2 diabetes.
    Lancet Diabetes Endocrinol. 2019;7:413.
    PubMed     Text format    


    Med Care

  49. BROWN SD, Fotuhi O, Grijalva CS, Tsai AL, et al
    A Randomized Study of Values Affirmation to Promote Interest in Diabetes Prevention Among Women With a History of Gestational Diabetes.
    Med Care. 2019 May 15. doi: 10.1097/MLR.0000000000001133.
    PubMed     Text format     Abstract available


    Metabolism

  50. QUICLET C, Dittberner N, Gassler A, Stadion M, et al
    Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice.
    Metabolism. 2019 May 17. pii: S0026-0495(19)30093.
    PubMed     Text format     Abstract available

  51. PERADZE N, Farr OM, Mantzoros CS
    Research developments in metabolism 2018.
    Metabolism. 2019;91:70-79.
    PubMed     Text format    


    Nature

  52. FLANNICK J, Mercader JM, Fuchsberger C, Udler MS, et al
    Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.
    Nature. 2019 May 22. pii: 10.1038/s41586-019-1231.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  53. SONGER TJ, Haymond MW, Glazner JE, Klingensmith GJ, et al
    Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience.
    Pediatr Diabetes. 2019 May 23. doi: 10.1111/pedi.12869.
    PubMed     Text format     Abstract available


    PLoS One

  54. HUANG TL, Hsiao FY, Chiang CK, Shen LJ, et al
    Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
    PLoS One. 2019;14:e0215248.
    PubMed     Text format     Abstract available

  55. COCCURELLO R, Nazio F, Rossi C, De Angelis F, et al
    Effects of caloric restriction on neuropathic pain, peripheral nerve degeneration and inflammation in normometabolic and autophagy defective prediabetic Ambra1 mice.
    PLoS One. 2018;13:e0208596.
    PubMed     Text format     Abstract available

  56. KIKUCHI H, Kanda E, Mori T, Sato H, et al
    Short-term prognosis of emergently hospitalized dialysis-independent chronic kidney disease patients: A nationwide retrospective cohort study in Japan.
    PLoS One. 2018;13:e0208258.
    PubMed     Text format     Abstract available


    Transplant Proc

  57. BORDA B, Lazar G, Kormanyos A, Domsik P, et al
    New-onset Diabetes Mellitus Following Successful Kidney Transplantation Facilitates Aortic Stiffening.
    Transplant Proc. 2019;51:1239-1243.
    PubMed     Text format     Abstract available

  58. BIRO B, Szabo RP, Illesy L, Balazsfalvi N, et al
    Regulatory T Cells in the Context of New-Onset Diabetes After Renal Transplant: A Single-Center Experience.
    Transplant Proc. 2019;51:1234-1238.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: